Avanos Medical Inc AVNS.N reported quarterly adjusted earnings of 17 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 29 cents. The lone analyst forecast for the quarter was for earnings of 15 cents per share.
Revenue rose 1.9% to $175.00 million from a year ago; analysts expected $165.50 million.
Avanos Medical Inc shares had fallen by 8.1% this quarter and lost 29.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 37.5% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
This summary was machine generated from LSEG data August 5 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | 0.15 | 0.17 | Beat |
Mar. 31 2025 | 0.18 | 0.26 | Beat |
Dec. 31 2024 | 0.40 | 0.42 | Beat |
Sep. 30 2024 | 0.35 | 0.36 | Beat |